{
  "image_filename": "figure_p1_det_0_017.png",
  "image_path": "Hsiao_et_al.__2023_/extracted/figures/figure_p1_det_0_017.png",
  "image_type": "Figure",
  "page_number": 1,
  "block_id": "det_0_017",
  "claim_id": "claim_006",
  "claim": "Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS).",
  "supports_claim": false,
  "explanation": "The image shows the title header of an original article titled 'Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age' along with the list of authors and the beginning of the abstract section. does not support the claim because the title page provides no information on Flublok\u2019s production platform, recombinant HA expression, insect cells, or BEVS. Note: Only the article title and authors are visible; no methodological or production details are available.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "The image shows the title header of an original article titled 'Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age' along with the list of authors and the beginning of the abstract section.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the title page provides no information on Flublok\u2019s production platform, recombinant HA expression, insect cells, or BEVS.",
    "confidence_notes": "Only the article title and authors are visible; no methodological or production details are available."
  }
}